IGM Biosciences, Inc. (IGMS)
NASDAQ: IGMS · IEX Real-Time Price · USD
11.18
-0.92 (-7.60%)
At close: Jul 26, 2024, 4:00 PM
12.35
+1.17 (10.47%)
After-hours: Jul 26, 2024, 6:12 PM EDT
IGM Biosciences Market Cap
IGM Biosciences has a market cap or net worth of $659.88 million as of July 26, 2024. Its market cap has increased by 47.03% in one year.
Market Cap
659.88M
Enterprise Value
406.72M
1-Year Change
47.03%
Ranking
Category
Stock Price
$11.18
Market Cap Chart
Since September 18, 2019, IGM Biosciences's market cap has decreased from $702.10M to $659.88M, a decrease of -6.01%. That is a compound annual growth rate of -1.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 714.20M | 47.17% |
| Dec 29, 2023 | 485.30M | -33.38% |
| Dec 30, 2022 | 728.50M | -23.48% |
| Dec 31, 2021 | 952.10M | -64.87% |
| Dec 31, 2020 | 2.71B | 132.63% |
| Dec 31, 2019 | 1.17B | 65.96% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alumis | 727.17M |
| Emergent BioSolutions | 723.15M |
| Weave Communications | 719.76M |
| Paragon 28 | 717.53M |
| Replimune Group | 716.01M |
| SIGA Technologies | 711.94M |
| REGENXBIO | 708.79M |
| ArriVent BioPharma | 708.06M |